BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are moving higher on Tuesday after the company reported 2024 fiscal-year earnings, showing multiple year-over-year increases. What To Know: The ...
SAN ANTONIO--(BUSINESS WIRE)--Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the ...
BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are trading lower by 50.7% to $1.48 during Wednesday’s session after the company announced a securities purchase agreement with institutional ...
SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces ...
In a challenging year for bioAffinity Technologies, the company's stock has reached a 52-week low, trading at just $0.65, with technical indicators from InvestingPro suggesting the stock is in ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from bioAffinity ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (BIAF) (Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics and targeted therapeutics, will present findings today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback